STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #811 by analyst upside · 2026-09-09
OABI
OmniAb, Inc.
Healthcare · Market Cap $616M · P/E 0x
ANALYST PRICE TARGET
+98.1%
implied upside to consensus target
Current Price $4.24
Consensus Target $8.4
Bull Target $11.0
Bear Target $5.0
Analysts Covering 5
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
5
Hold
0
Sell
0
52-Week Low $1.3
52-Week High $5.43
YTD Return +125.5%
FUNDAMENTALS
Market Cap $616M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-0.36
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $38M
Profit Margin -115.1%
52-WEEK RANGE
52-Week Low $1.3
52-Week High $5.43
Current Price $4.24
Bear Target $5.0
Bull Target $11.0
● Now $4.24 ● Target $8.4
TRADING DATA
Avg Volume 1.2M
YTD Return +125.5%
Analyst Count 5
Consensus Buy
Upside to Target +98.1%
Last Updated 2026-09-09

ANALYST SUMMARY

OmniAb, Inc. (OABI) is currently trading at $4.24 with a Wall Street consensus price target of $8.4, implying potential upside of 98.1% over the next 12 months. 5 analysts currently cover OABI, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $11.0, while the most cautious has a target of $5.0.

OABI operates in the Healthcare sector with a market capitalisation of $616M. The stock is up 125.5% year-to-date and is currently trading near the upper end of its 52-week range of $1.3 – $5.43.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for OABI, with each firm's 90-day track record across all stocks we track. See full firm rankings →

HC Wainwright & Co. reit
Buy → Buy 2026-08-17 31% win rate (48 calls)
RBC Capital - Reiterated
Outperform → Outperform 2025-08-07 Building track record
Benchmark reit
Buy → Buy 2025-05-12 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2025-03-27 Building track record
Benchmark - Reiterated
Buy → Buy 2025-03-20 Building track record
HC Wainwright & Co. reit
Buy → Buy 2025-03-19 31% win rate (48 calls)
Benchmark reit
Buy → Buy 2024-11-14 Building track record
HC Wainwright & Co. reit
Buy → Buy 2024-11-14 31% win rate (48 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
43
out of 100
Coverage depth
14/30
Consensus clarity
2/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →